TRADE SECRET AR226-3208 DuPont-8864 Study Title H-25124: Corrositex In Vitro Test Laboratory Project ID: DuPont-8864 Author: Carol Finlay, B.A.

Tateo to DuPont (Univ .

Tateo to DuPont (Univ.

AR226-2208 / Roger J Zipfel 11/02/2001 11:17 AM To: cc: Subject Robert F Pinchot/DEV/AE/DuPont@DuPont Debbie J Mulrooney/AE/DuPort@DuPont Re: C8 Particle Density D Debbie, I don't realty understand what you are asking for.

.-25 AM To: cc: Subject: Catherine A Barton/ABDuPont DuPont Kenneth N Wood/AE/DuPont@DuPont, James F Riley/CL/DuPonlQDuPonl.

DuPont de Nemours and Company (DuPont) that documents DuPont's intent to conduct a Perfluorooctanoic Acid (PFOA) Site-Related Environmental Assessment Program.

Participants: - John Butenhoff - Geary Olsen - Larry Zobel - Peter Gillies - John Green - Gerald Kennedy - Robin Leonard - Robert Rickard - Giovanni Costa 3M, toxicologist 3M, clinical epidemiologist 3M, occupational health physician DuPont, expert in lipid metabolism DuPont, statistician Dupont, toxicologist DuPont, epidemiologist DuPont, toxicologist Miteni, occupational health physician 2.

DuPont!

s g mu 2_S--Feb 200p4urified TELB DuPont Confidential Comary suze. bossncn T5CCH$A | I 25-Feb-2004 DuPont Confidential RE] J Current Program Status -Quick Overview 1 Brame DuPont Confidential gp, sues som rtcosnthsenw Major Ongoing Works+reams (1) IBiluepijuoQ ^uojna Ea J _ Timeline for Ongoing Workstreams | | | 207002004 DuPont Confidential 1

Ann Bradley/STB/DUP@ DUP, Robert L Ritchey/CL/DuPont@ DuPont cc: Subject: Presentador fo r W VD AQ M eeting Tom orrow For information.

', Buck, R.2,' DuPont, Haskell Laboratory for Health and Environmental Sciences, Newark, DE, USA2 DuPont, Wilmington, DE setae dupont presentations tracking document.doc Page 1 of 12 Society of Environmental Toxicology & Chemistry Summary of DuPont Presentations ABSTRACT- Perfluorinated compounds have unique properties and their measurement in various environmental matrices has received increased attention.

In over 50 years of use by DuPont and others, DuPont is not aware of any adverse human health effects that have been shown to be caused by PFOA.

Those Present: - Dr Randy Frame - Study Pathologist, DuPont Haskell Laboratories, Delaware, USA Dr John Hansen - Head of Pathology, DuPont Haskell Laboratories.

DuPont has no access to the entire Brookmar data set and Brookmar is not working at the direction of DuPont.

DuPont has no access to the entire Brookmar data set and Brookmar is not working at the direction of DuPont.